Pentobarbital will reduce the extent or impact of artemether/lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Coadministration with robust CYP3A4 inducers can lead to lowered serum concentrations and lack of antimalarial efficacy Soon after stopping a CYP3A4 inducer, given that the effects of the https://leonardof443xnc0.aboutyoublog.com/profile